Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $15.30 USD
Change Today +0.14 / 0.92%
Volume 6.3K
KNBWY On Other Exchanges
As of 8:10 PM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

kirin holdings co-spon adr (KNBWY) Snapshot

Previous Close
Day High
Day Low
52 Week High
07/31/15 - $15.38
52 Week Low
01/6/15 - $11.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

kirin holdings co-spon adr (KNBWY) Related Businessweek News

No Related Businessweek News Found

kirin holdings co-spon adr (KNBWY) Details

Kirin Holdings Company, Limited manufactures and sells alcohol and non-alcohol beverages, and pharmaceuticals and bio-chemical products in Japan, Oceania, Brazil, Southeast Asia, and other regions. The company operates through Japan Integrated Beverages, Overseas Integrated Beverages, Pharmaceutical and Bio-Chemicals, and Others segments. It offers beer, low-malt beer, and non-alcoholic beer; wines; ready-to-drink, whiskey, spirits, and other alcohol beverages; and coffee, black and Japanese tea, mineral water, and juices. The company also provides milk, cheese, and soda; and dairy products, such as butter and yoghurt, margarine, jams, and honey. In addition, it offers capital loan and equipment leasing services; operates and manages chain of Kirin City beer pubs; operates and manages event hall for concerts and sports events; and manufactures and sells food and four roses bourbon. The company was formerly known as Kirin Brewery Company, Limited and changed its name to Kirin Holdings Company, Limited in July 2007. Kirin Holdings Company, Limited was founded in 1885 and is headquartered in Tokyo, Japan.

39,894 Employees
Last Reported Date: 03/27/15
Founded in 1885

kirin holdings co-spon adr (KNBWY) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kirin holdings co-spon adr (KNBWY) Key Developments

Kyowa Hakko Kirin and Bristol-Myers Squibb Announces Immuno-Oncology Clinical Collaboration Studying Mogamulizumab and Opdivo (nivolumab) in Advanced Solid Tumors in the U.S

Kyowa Hakko Kirin Co. Ltd. and Bristol-Myers Squibb Company have entered into a clinical trial collaboration agreement to conduct a Phase 1/2 combination study with mogamulizumab, an anti-CCR4 antibody and Opdivo [2] (nivolumab), a PD-1 immune checkpoint inhibitor. The study, which will be conducted in the U.S., will focus on evaluating the safety, tolerability and anti-tumor activity of combining mogamulizumab and Opdivo as a potential treatment option for patients with advanced or metastatic solid tumors. Prior to this agreement, Kyowa Hakko Kirin, Bristol-Myers Squibband Ono Pharmaceutical Co. Ltd. entered into a clinical trial collaboration agreement to study the combination of mogamulizumab and Opdivo in Japan. Mogamulizumab and Opdivo are part of a new class of cancer treatments known as immunotherapies, which are designed to harness the body’s own immune system in fighting cancer by targeting distinct regulatory components of the immune system. The study will be conducted by Kyowa Hakko Kirin. About Mogamulizumab.

Kirin Holdings Company, Limited Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Six Months Ending June 30, 2015 and Year Ending December 31, 2015

Kirin Holdings Company, Limited reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company's sales were JPY 515,298 million compared to JPY 528,730 million a year ago. Operating income was JPY 26,261 million compared to JPY 30,048 million a year ago. Ordinary income was JPY 25,630 million compared to JPY 28,597 million a year ago. Income before income taxes and minority interests was JPY 28,984 million compared to JPY 27,289 million a year ago. Net income was JPY 13,376 million or JPY 14.66 per diluted share compared to JPY 11,102 million or JPY 11.90 per diluted share a year ago. Normalized EBITDA was JPY 56.0 billion or JPY 25 per share compared to JPY 66.4 billion or JPY 30 per share a year ago. For the six months ending June 30, 2015, the company expects sales of JPY 1,090,000 million and operating income of JPY 54,000 million. For the year ending December 31, 2015, the company expects sales of JPY 2,270,000 million, operating income of JPY 139,000 million, ordinary income of JPY 122,000 million, net income of JPY 62,000 million or JPY 67.94 per share and normalized EBITDA of JPY 276.0 billion or normalized EPS of JPY 121.

Kirin Holdings Company, Limited Provides Dividend Guidance for the Second Quarter of 2015; Provides Dividend Guidance for the Fiscal Year Ending December 31, 2015

Kirin Holdings Company, Limited provided dividend guidance for the second quarter of 2015 is ¥19.00 per share. The company also announced dividend of ¥19.00 per share for the fiscal year ending December 31, 2015.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KNBWY:US $15.30 USD +0.14

KNBWY Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ajinomoto Co Inc ¥2,830 JPY -22.50
Asahi Group Holdings Ltd ¥4,171 JPY +14.00
Carlsberg A/S kr592.00 DKK -6.00
Fomento Economico Mexicano SAB de CV $146.10 MXN -1.64
MEIJI Holdings Co Ltd ¥17,620 JPY -10.00
View Industry Companies

Industry Analysis


Industry Average

Valuation KNBWY Industry Range
Price/Earnings 48.8x
Price/Sales 0.8x
Price/Book 2.0x
Price/Cash Flow 22.2x
TEV/Sales 0.2x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KIRIN HOLDINGS CO-SPON ADR, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at